Vaccine News and Research

Latest Vaccine News and Research

Which biomarkers can help predict severe COVID-19?

The ability to detect potentially fatal illness early on in the course of the disease would enable a swift prioritization of these high-risk individuals for treatment. A new preprint on the medRxiv* server presents an array of biomarkers that may help achieve this laudable goal.

15 Mar 2021

Neutralizing nanobodies effective against SARS-CoV-2 variants

Nanobodies have different mechanisms to neutralize viruses, and some target epitopes not accessible to monoclonal antibodies, making them an alternative for developing therapies for COVID-19.

15 Mar 2021

The boom in out-of-state telehealth threatens in-state providers

When the Hazelden Betty Ford Foundation began offering telehealth services in Montana in early February, the nation's largest nonprofit addiction treatment provider promised quality care for far-flung residents without their even having to leave home.

15 Mar 2021

Covid cases plummet 83% among nursing home staffers despite vaccine hesitancy

Joan Phillips, a certified nursing assistant in a Florida nursing home, loved her job but dreaded the danger of going to work in the pandemic. When vaccines became available in December, she jumped at the chance to get one.

15 Mar 2021

Study suggests COVID-19 vaccine acceptance on the rise in UK

A team of researchers in the UK recently conducted a two-wave survey on the hesitancy of individuals to receive COVID-19 vaccination.

15 Mar 2021

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

In a recent bioRxiv preprint research paper, Botond Z. Igyártó and colleagues from Thomas Jefferson University demonstrated the inflammatory nature of the lipid nanoparticles (LNPs).

15 Mar 2021

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

A recent study, currently available on the bioRxiv preprint server, indicates that a pair of dual-action monoclonal antibodies derived from an original 2003 SARS survivors could play an important role in the fight against coronavirus disease 2019 (COVID-19) due to their broadly neutralizing activity and the engagement of the immune system via effector function capabilities.

14 Mar 2021

CUNY SPH receives prestigious Harrison C. Spencer Award for Outstanding Community Service

At its 2021 Annual Meeting this month, the Association of Schools and Programs of Public Health (ASPPH) will present the CUNY Graduate School of Public Health and Health Policy with the Harrison C. Spencer Award for Outstanding Community Service.

13 Mar 2021

New vaccination method aims at comprehensive protection against all known influenza mutations

One shot, protected forever: This would be a dream come true regarding influenza vaccinations. So far, vaccination against influenza did not provide a lasting protection.

13 Mar 2021

Neutralizing antibodies induced by COVID-19 vaccines less effective against new variants

SARS-CoV-2, the virus that causes COVID-19, has mutated throughout the pandemic. New variants of the virus have arisen throughout the world, including variants that might possess increased ability to spread or evade the immune system.

13 Mar 2021

SARS-CoV-2 did not change much when it jumped from bats to human hosts

How much did SARS-CoV-2 need to change in order to adapt to its new human host? In a research article published in the open access journal PLOS Biology Oscar MacLean, Spyros Lytras at the University of Glasgow, and colleagues, show that since December 2019 and for the first 11 months of the SARS-CoV-2 pandemic there has been very little 'important' genetic change observed in the hundreds of thousands of sequenced virus genomes.

13 Mar 2021

Single-dose vaccines may provide sufficient immunization for individuals previously infected with SARS-CoV-2

A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.

12 Mar 2021

An overview of the BNT162b2 COVID-19 vaccine by Pfizer-BioNTech

In a study published in the journal Drugs, a researcher tackled the approval of Pfizer-BioNTech’s COVID-19 vaccine, which has now been used in many countries.

12 Mar 2021

To extract more doses per vial, vaccinators put squeeze on FDA to relax vaccine handling advice

President Joe Biden has promised enough covid vaccine to immunize every willing adult by June 1. But right now, the gap between supply and demand is so dramatic that vaccinators are discovering ways to suck the final drops out of each vaccine vial — if federal regulators will let them.

12 Mar 2021

Antibodies to SARS-CoV-2 spike protein and RBD detected in saliva of mRNA-vaccine recipients

A team of researchers from the US and the Netherlands recently reported that antibodies to the spike protein and the RBD are detected in saliva samples from healthcare workers vaccinated with mRNA vaccines.

12 Mar 2021

U.S. Congress has clear opportunity to supercharge global health R&D, shows report

The U.S. Congress and Biden-Harris administration have a clear opportunity to supercharge global health research and development (R&D) in the wake of a pandemic that has revealed both the sector's chronic neglect and amazing potential.

12 Mar 2021

Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines

Much like coronavirus, circulating HIV-1 viruses mutate into diverse variants that pose challenges for scientists developing vaccines to protect people from HIV/AIDS.

12 Mar 2021

COVID-19 mRNA vaccines can reduce risk of asymptomatic COVID-19 infection

Ten days after receiving a second dose of a messenger RNA, or mRNA, vaccine for COVID-19, patients without COVID-19 symptoms are far less likely to test positive and unknowingly spread COVID-19, compared to patients who have not been vaccinated for COVID-19.

12 Mar 2021

Spike protein mutations in SARS-CoV-2 variants help resist antibody neutralization

Researchers based in Beijing and Shenzhen, China, report that they have identified mutations in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may allow variant strains to avoid neutralization by monoclonal antibodies and convalescent blood plasma.

11 Mar 2021

Delaying second dose of Pfizer-BioNTech SARS-CoV-2 vaccine may be feasible in some cases

Researchers in Spain have conducted the most extensive study to date investigating the effectiveness of vaccinating healthcare workers with a single dose of the Pfizer-BioNTech vaccine to protect against coronavirus disease 2019 (COVID-19).

11 Mar 2021

Vaccine News and Research

Latest Vaccine News and Research

Which biomarkers can help predict severe COVID-19?

Neutralizing nanobodies effective against SARS-CoV-2 variants

The boom in out-of-state telehealth threatens in-state providers

Covid cases plummet 83% among nursing home staffers despite vaccine hesitancy

Study suggests COVID-19 vaccine acceptance on the rise in UK

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

CUNY SPH receives prestigious Harrison C. Spencer Award for Outstanding Community Service

New vaccination method aims at comprehensive protection against all known influenza mutations

Neutralizing antibodies induced by COVID-19 vaccines less effective against new variants

SARS-CoV-2 did not change much when it jumped from bats to human hosts

Single-dose vaccines may provide sufficient immunization for individuals previously infected with SARS-CoV-2

An overview of the BNT162b2 COVID-19 vaccine by Pfizer-BioNTech

To extract more doses per vial, vaccinators put squeeze on FDA to relax vaccine handling advice

Antibodies to SARS-CoV-2 spike protein and RBD detected in saliva of mRNA-vaccine recipients

U.S. Congress has clear opportunity to supercharge global health R&D, shows report

Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines

COVID-19 mRNA vaccines can reduce risk of asymptomatic COVID-19 infection

Spike protein mutations in SARS-CoV-2 variants help resist antibody neutralization

Delaying second dose of Pfizer-BioNTech SARS-CoV-2 vaccine may be feasible in some cases

eBook: Advancing infectious disease vaccine development eBook

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Vaccine News and Research

Latest Vaccine News and Research

eBook: Advancing infectious disease vaccine development eBook

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Newsletters you may be interested in